Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ADPT will decline by -9.59% over the next 2 Weeks and hit $12.57 by Tuesday, April 7, 2026. In that time frame, ADPT's share price is expected to range between $11.63 and $13.56.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 7, 2026 | 11.63 | 12.57 | 13.56 |
| Apr 6, 2026 | 11.64 | 12.59 | 13.48 |
| Apr 3, 2026 | 11.54 | 12.53 | 13.42 |
| Apr 2, 2026 | 11.53 | 12.42 | 13.38 |
| Apr 1, 2026 | 11.83 | 12.76 | 13.63 |
| Mar 31, 2026 | 12.20 | 13.17 | 14.12 |
| Mar 30, 2026 | 12.21 | 13.19 | 14.18 |
| Mar 27, 2026 | 12.19 | 13.13 | 14.04 |
| Mar 26, 2026 | 12.10 | 13.02 | 13.97 |
| Mar 25, 2026 | 12.44 | 13.36 | 14.25 |
ADPT shares rose +1.76% in Tuesday, March 24, 2026's trading session, rising from a previous close of $13.66 to move at $13.90. The stock demonstrated notable intraday movement (see ADPT's key stats for a full breakdown), fluctuating between $13.41 and $13.95, a +3.99% trading range. While recent weeks have seen some volatility, ADPT has managed to secure a -2.25% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.76M shares changing hands, 487.62K more than the previous session. This amounted to $24.50M in total market activity.
Will ADPT Continue Its Downward Trend?
According to analyst ratings and projections for ADPT, Adaptive Biotechnologies Corporation shares are anticipated to decrease by -2.49%, potentially reaching $13.56 per share by April 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for ADPT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the ADPT stock forecast, now is not the best time to buy ADPT stock because its current trading price is +10.60% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ADPT covering social and institutional perspectives.
ADPT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ADPT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.11% to 44.11%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.04%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.57%, maintains a neutral outlook for the long term. Insights into ADPT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Adaptive Biotechnologies Short-Term Forecasts
ADPT Forecast For Next 5 Days
Our algorithm anticipates Adaptive Biotechnologies (ADPT) stock could hit $13.30 by Mar 31, 2026. This represents a -4.33% fall from today's price, following a -2.14% change over the past five days.
ADPT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Adaptive Biotechnologies Corporation (ADPT) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $12.22, which would mean a -12.09% decrease from the current price of $13.90. Projections for this period range from a high of $15.41 to a low of $9.93.
ADPT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Adaptive Biotechnologies's price over the next three months point to a rise. ADPT stock is expected to peak at $32.49 on Jun 16, 2026 after potentially dipping to $22.27 on May 08, 2026. On average, ADPT is likely to trade around $27.00 in the coming 90 days.
Adaptive Biotechnologies Stock Forecast 2025
Based on our predictive models, Adaptive Biotechnologies (ADPT) is expected to trade between $22.27 and $45.37 throughout 2026. This would result in an average price of $33.98, potentially offering investors a +144.46% return from current levels.
Adaptive Biotechnologies Corporation Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Adaptive Biotechnologies Corporation (ADPT) is positioned to show a strong performance in March 2026. The price is predicted to move between $26.37 and $27.40, settling at an average of $26.89. This could translate to a +93.45% gain.
April 2026
Based on current market signals, Adaptive Biotechnologies Corporation is projected to trend april 2026. We forecast a trading range from $23.03 to $27.99, with a likely average price of $25.83. Investors could expect a potential return of +85.83%.
May 2026
Our predictive algorithms indicate Adaptive Biotechnologies Corporation stock may see a shift in May 2026. The expected range spans $22.27–$27.64, with an average target of $24.71. This represents a positive outlook and a possible gain of +77.77%.
June 2026
Analyzing established trends, Adaptive Biotechnologies Corporation looks set to move in June 2026. Projections place the stock between $28.18 and $32.49, averaging around $31.02. This suggests a +123.17% gain from current levels.
July 2026
Market indicators suggest Adaptive Biotechnologies Corporation could experience notable changes during July 2026. Prices could fluctuate within $29.30 to $35.02, with a midpoint forecast of $31.71. The stock might deliver a +128.13% gain.
August 2026
Forecasting for August 2026, models estimate that Adaptive Biotechnologies Corporation may undergo key fluctuations. If trends hold, the stock might trade between $32.78 and $36.37, averaging $34.13. This signals a positive trajectory with potential returns around +145.54%.
September 2026
According to our latest forecast models, Adaptive Biotechnologies Corporation (ADPT) is positioned to show a strong performance in September 2026. The price is predicted to move between $31.60 and $40.05, settling at an average of $35.44. This could translate to a +154.96% gain.
October 2026
Based on current market signals, Adaptive Biotechnologies Corporation is projected to trend october 2026. We forecast a trading range from $34.61 to $44.52, with a likely average price of $39.17. Investors could expect a potential return of +181.80%.
November 2026
Our predictive algorithms indicate Adaptive Biotechnologies Corporation stock may see a shift in November 2026. The expected range spans $41.62–$45.37, with an average target of $42.76. This represents a positive outlook and a possible gain of +207.63%.
December 2026
Analyzing established trends, Adaptive Biotechnologies Corporation looks set to move in December 2026. Projections place the stock between $41.36 and $45.32, averaging around $42.37. This suggests a +204.82% gain from current levels.
January 2027
Market indicators suggest Adaptive Biotechnologies Corporation could experience notable changes during January 2027. Prices could fluctuate within $41.39 to $46.68, with a midpoint forecast of $43.03. The stock might deliver a +209.57% gain.
February 2027
Forecasting for February 2027, models estimate that Adaptive Biotechnologies Corporation may undergo key fluctuations. If trends hold, the stock might trade between $36.75 and $45.52, averaging $39.76. This signals a positive trajectory with potential returns around +186.04%.
March 2027
According to our latest forecast models, Adaptive Biotechnologies Corporation (ADPT) is positioned to show a strong performance in March 2027. The price is predicted to move between $30.41 and $36.91, settling at an average of $31.38. This could translate to a +125.76% gain.
ADPT's history of dividends and stock splits also plays a role in long-term investor confidence.

